Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 190.43

-0.7%

Feb 6 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew H who wrote (8015)	9/29/1997 5:41:00 PM
From: biowa	of 32384

Andy and Henry, >>The majority of the higher dose drug-related adverse events consisted of reversible neutropenia (a reduction of white blood cells) without infectious complications and elevation of serum triglycerides,<< Gotta disagree with you. Since infectious complications are a potential outcome of neutropenia (and IMO elevated serum triglycerides aren't), I suspect that the "without" merely modifies neutropenia and refers only to infectious complications. Thus, it would appear that elevated triglycerides WERE observed... Sorry to interrupt; I think I wade safely back to shore now. <g> biowa

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next